Abstract
Open source software that enable research and development of machine learning (ML) models for clinical use cases are fragmented, poorly maintained and fall short in functionality. CyclOps is a software framework designed to address this gap and help accelerate the development of ML models for health. In this paper, we describe the architecture, APIs and implementation details of CyclOps, while providing benchmarks on example clinical use cases. We emphasize that CyclOps is developed to be researcher friendly, while providing APIs for building end-to-end pipelines for model development as well as deployment. We adopt software engineering and ML operations (MLOps) best practices, while providing support for handling large volumes of health data. The design of the framework is centered around the notion of iterative and cyclical development of the overall ML system, which consists of data, model development and monitoring pipelines. The core CyclOps package can be installed through the Python Package Index (PyPI) and the source code is available at https://github.com/VectorInstitute/cyclops.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Vector Institute, in collaboration with the GEMINI initiative.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research ethics board approval was obtained from the University Health Network (Toronto), Sunnybrook Health Sciences Centre (Toronto) and St. Michael's Hospital (Toronto) through the integrated Clinical Trials Ontario platform, with St. Michael's Hospital as the Board of Record (CTO project ID: 1394). Research ethics board approval was also obtained from Trillium Health Partners (Mississauga; REB# 742) and Mount Sinai Hospital (Toronto; REB# 15-0075-C).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
amritk{at}vectorinstitute.ai
vallijah.subasri{at}sickkids.ca
kaden.mckeen{at}uhn.ca
ali.kore{at}vectorinstitute.ai
franklin.ogidi{at}vectorinstitute.ai
mahshid.alinoori{at}vectorinstitute.ai
nadim.lalani{at}vectorinstitute.ai
azra.dhalla{at}vectorinstitute.ai
amol.verma{at}mail.utoronto.ca
fahad.razak{at}mail.utoronto.ca
deval.pandya{at}vectorinstitute.ai
elham.dolatabadi{at}vectorinstitute.ai
Order of authors updated. Title of paper updated on medarxiv to not have all caps.
Data Availability
All data produced in the present study are available upon reasonable request to the authors, subject to governance policies of datasets used for the experiments.
